In another recent study using NOD-H2h4 mice, thyroiditis was more prevalent with anti-CTLA-4 treatment, but more severe symptoms were seen following anti-PD-1 administration and was correlated with immune cell infiltration in thyroidal tissues. Here, CTLA4 is linked to thyroiditis.